Prestige Consumer Healthcare (PBH) Revenue Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Revenue Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.37% |
| Sep 30, 2025 | -3.41% |
| Jun 30, 2025 | -6.59% |
| Mar 31, 2025 | 7.05% |
| Dec 31, 2024 | 2.68% |
| Sep 30, 2024 | -0.88% |
| Jun 30, 2024 | -4.36% |
| Mar 31, 2024 | -3.11% |
| Dec 31, 2023 | 2.62% |
| Sep 30, 2023 | -1.02% |
| Jun 30, 2023 | 0.81% |
| Mar 31, 2023 | 7.09% |
| Dec 31, 2022 | 0.38% |
| Sep 30, 2022 | 4.72% |
| Jun 30, 2022 | 2.93% |
| Mar 31, 2022 | 12.27% |
| Dec 31, 2021 | 14.94% |
| Sep 30, 2021 | 16.34% |
| Jun 30, 2021 | 17.34% |
| Mar 31, 2021 | -5.36% |